1,3-dipropyl-8-cyclopentylxanthine has been researched along with adenylyl imidodiphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, T; Cunha, RA; Oliveira, CR; Richardson, PJ; Rodrigues, RJ | 1 |
De Lorenzo, S; Losavio, A; Muchnik, S; Veggetti, M | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and adenylyl imidodiphosphate
Article | Year |
---|---|
Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Astrocytoma; Calcium; Cell Line; Cell Line, Tumor; Glutamic Acid; Hippocampus; Kidney; Male; Potassium; Pyramidal Cells; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Presynaptic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Recombinant Fusion Proteins; RNA, Messenger; Subcellular Fractions; Suramin; Synaptosomes; Transfection; Triazines; Triazoles; Xanthines | 2005 |
Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction.
Topics: Acetylcholine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; In Vitro Techniques; Membrane Potentials; Mice; Neural Inhibition; Neuromuscular Junction; Potassium; Presynaptic Terminals; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Suramin; Xanthines | 2006 |